Literature DB >> 22560666

Gd3+ complex-modified NaLuF4-based upconversion nanophosphors for trimodality imaging of NIR-to-NIR upconversion luminescence, X-Ray computed tomography and magnetic resonance.

Ao Xia1, Min Chen, Yuan Gao, Dongmei Wu, Wei Feng, Fuyou Li.   

Abstract

Multimodality molecular imaging has recently attracted much attention, because it can take advantage of individual imaging modalities by fusing together information from several molecular imaging techniques. Herein, we report a multifunctional lanthanide-based nanoparticle for near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence (UCL), X-ray computed tomography (CT) and T(1)-enhanced magnetic resonance (MR) trimodality in-vivo imaging. By careful selection of the lanthanide elements, core-shell structured lanthanide-based nanoparticles, NaLuF(4):Yb(3+),Tm(3+)@SiO(2)-GdDTPA nanoparticles (UCNP@SiO(2)-GdDTPA) have been designed and synthesized. We also prove that the application of UCNP@SiO(2)-GdDTPA for NIR-to-NIR UCL, CT and MRI multi-modality in-vivo imaging can be established successfully. In addition, the biological toxicity of UCNP@SiO(2)-GdDTPA is evaluated by the methyl thiazolyl tetrazolium (MTT) assay and histological analysis of viscera sections.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560666     DOI: 10.1016/j.biomaterials.2012.04.025

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  23 in total

Review 1.  Recent Advances in Higher-Order, Multimodal, Biomedical Imaging Agents.

Authors:  James Rieffel; Upendra Chitgupi; Jonathan F Lovell
Journal:  Small       Date:  2015-07-16       Impact factor: 13.281

Review 2.  Upconversion nanoparticles: design, nanochemistry, and applications in theranostics.

Authors:  Guanying Chen; Hailong Qiu; Paras N Prasad; Xiaoyuan Chen
Journal:  Chem Rev       Date:  2014-03-10       Impact factor: 60.622

Review 3.  Targeted nanotechnology for cancer imaging.

Authors:  Randall Toy; Lisa Bauer; Christopher Hoimes; Ketan B Ghaghada; Efstathios Karathanasis
Journal:  Adv Drug Deliv Rev       Date:  2014-08-09       Impact factor: 15.470

4.  Simultaneous Enhancement of Photoluminescence, MRI Relaxivity, and CT Contrast by Tuning the Interfacial Layer of Lanthanide Heteroepitaxial Nanoparticles.

Authors:  Sha He; Noah J J Johnson; Viet Anh Nguyen Huu; Esther Cory; Yuran Huang; Robert L Sah; Jesse V Jokerst; Adah Almutairi
Journal:  Nano Lett       Date:  2017-07-07       Impact factor: 11.189

Review 5.  Multifunctional nanoparticles for drug delivery and molecular imaging.

Authors:  Gang Bao; Samir Mitragotri; Sheng Tong
Journal:  Annu Rev Biomed Eng       Date:  2013-04-29       Impact factor: 9.590

6.  Iodinated oil-loaded, fluorescent mesoporous silica-coated iron oxide nanoparticles for magnetic resonance imaging/computed tomography/fluorescence trimodal imaging.

Authors:  Sihan Xue; Yao Wang; Mengxing Wang; Lu Zhang; Xiaoxia Du; Hongchen Gu; Chunfu Zhang
Journal:  Int J Nanomedicine       Date:  2014-05-21

7.  Current Advances in Lanthanide-Doped Upconversion Nanostructures for Detection and Bioapplication.

Authors:  Cailing Chen; Chunguang Li; Zhan Shi
Journal:  Adv Sci (Weinh)       Date:  2016-04-27       Impact factor: 16.806

8.  Self-assembled gemcitabine-gadolinium nanoparticles for magnetic resonance imaging and cancer therapy.

Authors:  Lele Li; Rong Tong; Mengyuan Li; Daniel S Kohane
Journal:  Acta Biomater       Date:  2016-01-27       Impact factor: 8.947

Review 9.  Nanoparticle-based systems for T(1)-weighted magnetic resonance imaging contrast agents.

Authors:  Derong Zhu; Fuyao Liu; Lina Ma; Dianjun Liu; Zhenxin Wang
Journal:  Int J Mol Sci       Date:  2013-05-21       Impact factor: 5.923

10.  An anion-induced hydrothermal oriented-explosive strategy for the synthesis of porous upconversion nanocrystals.

Authors:  Peiyu Qiu; Rongjin Sun; Guo Gao; Chunlei Zhang; Bin Chen; Naishun Yan; Ting Yin; Yanlei Liu; Jingjing Zhang; Yao Yang; Daxiang Cui
Journal:  Theranostics       Date:  2015-02-06       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.